• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Establishment and Validation of Pathogenic CS17 and CS19 Enterotoxigenic Escherichia coli Challenge Models in the New World Primate Aotus nancymaae.新世界灵长类动物南迪熊猴致病性 CS17 和 CS19 肠毒素性大肠杆菌攻毒模型的建立和验证。
Infect Immun. 2021 Feb 16;89(3). doi: 10.1128/IAI.00479-20.
2
Establishment, Validation, and Application of a New World Primate Model of Enterotoxigenic Disease for Vaccine Development.建立、验证和应用一种新的食源性疾病的新世界灵长类动物模型用于疫苗开发。
Infect Immun. 2019 Jan 24;87(2). doi: 10.1128/IAI.00634-18. Print 2019 Feb.
3
Evaluation of the immunogenicity and protective efficacy of a recombinant CS6-based ETEC vaccine in an Aotus nancymaae CS6 + ETEC challenge model.评价基于 CS6 的重组 ETEC 疫苗在 Aotus nancymaae CS6+ETEC 攻毒模型中的免疫原性和保护效力。
Vaccine. 2021 Jan 15;39(3):487-494. doi: 10.1016/j.vaccine.2020.12.034. Epub 2020 Dec 21.
4
Hyperimmune Bovine Colostral Anti-CS17 Antibodies Protect Against Enterotoxigenic Escherichia coli Diarrhea in a Randomized, Doubled-Blind, Placebo-Controlled Human Infection Model.高免牛初乳抗 CS17 抗体在随机、双盲、安慰剂对照的人体感染模型中预防肠产毒性大肠杆菌腹泻。
J Infect Dis. 2019 Jul 2;220(3):505-513. doi: 10.1093/infdis/jiz135.
5
Oral administration of an anti-CfaE secretory IgA antibody protects against Enterotoxigenic Escherichia coli diarrheal disease in a nonhuman primate model.口服抗 CfaE 分泌型 IgA 抗体可预防非人灵长类动物肠毒素性大肠杆菌腹泻病。
Vaccine. 2020 Feb 28;38(10):2333-2339. doi: 10.1016/j.vaccine.2020.01.064. Epub 2020 Jan 31.
6
Volunteer challenge with enterotoxigenic Escherichia coli that express intestinal colonization factor fimbriae CS17 and CS19.志愿者挑战表达肠致病性大肠杆菌肠定植因子菌毛 CS17 和 CS19
J Infect Dis. 2011 Jul 1;204(1):60-4. doi: 10.1093/infdis/jir220.
7
Immunogenicity of a prototype enterotoxigenic Escherichia coli adhesin vaccine in mice and nonhuman primates.一种原型产肠毒素大肠杆菌黏附素疫苗在小鼠和非人灵长类动物中的免疫原性。
Vaccine. 2016 Jan 4;34(2):284-291. doi: 10.1016/j.vaccine.2015.11.017. Epub 2015 Nov 18.
8
Review on pathogenicity mechanism of enterotoxigenic Escherichia coli and vaccines against it.肠致病性大肠杆菌的致病机制及疫苗研究进展
Microb Pathog. 2018 Apr;117:162-169. doi: 10.1016/j.micpath.2018.02.032. Epub 2018 Feb 21.
9
Evaluation of the Immunogenicity and Protective Efficacy of an Enterotoxigenic Escherichia coli CFA/I Adhesin-Heat-Labile Toxin Chimera.肠毒素性大肠杆菌 CFA/I 黏附素-不耐热肠毒素嵌合体的免疫原性和保护效力评估。
Infect Immun. 2020 Oct 19;88(11). doi: 10.1128/IAI.00252-20.
10
Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates.过表达肠产毒性大肠杆菌(ETEC)定植因子的策略,用于构建口服全细胞灭活 ETEC 疫苗候选物。
Appl Microbiol Biotechnol. 2012 Mar;93(6):2291-300. doi: 10.1007/s00253-012-3930-6. Epub 2012 Feb 16.

引用本文的文献

1
Beyond FimH: Diversity and Relevance of Carbohydrate-Binding Fimbrial Proteins in Escherichia coli.超越菌毛粘附素FimH:大肠杆菌中碳水化合物结合菌毛蛋白的多样性及相关性
Chembiochem. 2025 Sep 15;26(17):e202500433. doi: 10.1002/cbic.202500433. Epub 2025 Jul 30.

本文引用的文献

1
Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial.口服、灭活、肠产毒性大肠杆菌疫苗 ETVAX 在孟加拉国儿童和婴儿中的安全性和免疫原性:一项双盲、随机、安慰剂对照的 1/2 期临床试验。
Lancet Infect Dis. 2020 Feb;20(2):208-219. doi: 10.1016/S1473-3099(19)30571-7. Epub 2019 Nov 19.
2
Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge.含dmLT佐剂的减毒活产肠毒素大肠杆菌(ETEC)疫苗可保护人类志愿者抵御强毒性实验性ETEC攻击。
Vaccine. 2019 Mar 28;37(14):1978-1986. doi: 10.1016/j.vaccine.2019.02.025. Epub 2019 Feb 21.
3
Colonization factors among enterotoxigenic Escherichia coli isolates from children with moderate-to-severe diarrhea and from matched controls in the Global Enteric Multicenter Study (GEMS).肠毒素性大肠杆菌分离株中的定植因子在全球肠道多中心研究(GEMS)中中重度腹泻患儿和匹配对照中的比较。
PLoS Negl Trop Dis. 2019 Jan 4;13(1):e0007037. doi: 10.1371/journal.pntd.0007037. eCollection 2019 Jan.
4
Establishment, Validation, and Application of a New World Primate Model of Enterotoxigenic Disease for Vaccine Development.建立、验证和应用一种新的食源性疾病的新世界灵长类动物模型用于疫苗开发。
Infect Immun. 2019 Jan 24;87(2). doi: 10.1128/IAI.00634-18. Print 2019 Feb.
5
Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016.志贺菌和肠产毒性大肠杆菌腹泻导致的发病和死亡:1990-2016 年全球疾病负担研究。
Lancet Infect Dis. 2018 Nov;18(11):1229-1240. doi: 10.1016/S1473-3099(18)30475-4. Epub 2018 Sep 25.
6
Critical Role of Zinc in a New Murine Model of Enterotoxigenic Escherichia coli Diarrhea.锌在一种新的产肠毒素性大肠杆菌腹泻的小鼠模型中的关键作用。
Infect Immun. 2018 Jun 21;86(7). doi: 10.1128/IAI.00183-18. Print 2018 Jul.
7
Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy.考虑使用肠致病性大肠杆菌(ETEC)和志贺氏菌疾病负担估计值来指导疫苗开发策略。
Vaccine. 2019 Nov 28;37(50):7372-7380. doi: 10.1016/j.vaccine.2017.09.083. Epub 2017 Oct 12.
8
Travelers' Diarrhea: An Update on the Incidence, Etiology, and Risk in Military Deployments and Similar Travel Populations.旅行者腹泻:军事部署及类似旅行人群中的发病率、病因及风险最新情况
Mil Med. 2017 Sep;182(S2):4-10. doi: 10.7205/MILMED-D-17-00064.
9
Status of vaccine research and development for enterotoxigenic Escherichia coli.产肠毒素大肠杆菌疫苗研发现状
Vaccine. 2016 Jun 3;34(26):2880-2886. doi: 10.1016/j.vaccine.2016.02.076. Epub 2016 Mar 15.
10
Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge.用菌毛尖端黏附素对母体进行疫苗接种及对新生小鼠进行被动保护以抵御致死性人肠毒素型大肠杆菌攻击。
Infect Immun. 2015 Dec;83(12):4555-64. doi: 10.1128/IAI.00858-15. Epub 2015 Sep 14.

新世界灵长类动物南迪熊猴致病性 CS17 和 CS19 肠毒素性大肠杆菌攻毒模型的建立和验证。

Establishment and Validation of Pathogenic CS17 and CS19 Enterotoxigenic Escherichia coli Challenge Models in the New World Primate Aotus nancymaae.

机构信息

Bacteriology Department, Naval Medical Research Unit No. 6, APO, Lima, Peru

Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.

出版信息

Infect Immun. 2021 Feb 16;89(3). doi: 10.1128/IAI.00479-20.

DOI:10.1128/IAI.00479-20
PMID:33288648
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8097270/
Abstract

Enterotoxigenic (ETEC) is a common cause of diarrheal illness in the military, travelers, and children living in low- to middle-income countries. Increased antibiotic resistance, the absence of a licensed vaccine, and the lack of broadly practical therapeutics perpetuate the significant health and financial burden resulting from ETEC infection. A critical step in the evaluation of vaccines and therapeutics is preclinical screening in a relevant animal disease model that closely replicates human disease. We previously developed a diarrheal model of class 5a colonization factor (CF) CFA/I-expressing ETEC in the New World owl monkey species using ETEC strain H10407. In order to broaden the use of the model, we report here on the development of models of ETEC expressing the class 5b CFs CS17 and CS19 with strains LSN03-016011/A and WS0115A, respectively. For both models, we observed diarrheal attack rates of ≥80% after oral inoculation with 5 × 10 CFU of bacteria. These models will aid in assessing the efficacy of future ETEC vaccine candidates and therapeutics.

摘要

产肠毒素性(ETEC)是军队、旅行者和生活在中低收入国家的儿童腹泻病的常见病因。抗生素耐药性的增加、缺乏许可疫苗以及缺乏广泛实用的治疗方法,使 ETEC 感染造成的重大健康和财政负担持续存在。疫苗和疗法评估的关键步骤是在密切模拟人类疾病的相关动物疾病模型中进行临床前筛选。我们之前使用 ETEC 菌株 H10407 在新世界猫头鹰猴物种中开发了表达 5a 类定植因子(CF)CFA/I 的腹泻模型。为了扩大该模型的用途,我们在此报告了分别用菌株 LSN03-016011/A 和 WS0115A 表达 5b 类 CFs CS17 和 CS19 的 ETEC 模型的开发情况。对于这两种模型,我们观察到经口接种 5×10 CFU 细菌后,腹泻攻击率均≥80%。这些模型将有助于评估未来 ETEC 疫苗候选物和疗法的疗效。